论文部分内容阅读
目的:研究糖尿病合并脑梗塞采用脑心通胶囊联合奥扎格雷钠治疗的临床价值。方法:选取本院在2013年6月至2015年2月收治的60例糖尿病合并脑梗塞患者,按照治疗方法将其分为观察组和对照组各30例,观察组脑心通胶囊+奥扎格雷钠治疗,对照组奥扎格雷钠治疗。结果:观察组患者临床治疗总有效率93.3%显著优于对照组患者73.3%,治疗后神经功能缺损程度评分显著低于对照组患者和治疗前,且治疗后全血高切黏度、全血低切黏度、纤维蛋白原、红细胞聚集指数和血浆黏度指标均显著低于对照组患者和治疗前,差异具有统计学意义(P<0.05)。结论:脑心通胶囊+奥扎格雷钠可显著改善糖尿病合并脑梗塞患者临床症状,改善患者预后。
Objective: To study the clinical value of Naoxintong capsule combined with ozagrel sodium in the treatment of diabetes complicated with cerebral infarction. Methods: Sixty patients with diabetes mellitus complicated with cerebral infarction admitted from June 2013 to February 2015 in our hospital were divided into observation group (30 cases) and control group (30 cases), observation group (n = Gray sodium treatment, the control group Ozagrel sodium treatment. Results: The total effective rate of clinical observation group was 93.3%, which was significantly better than 73.3% of the control group. After treatment, the score of neurological deficit was significantly lower than that of the control group and before treatment. After treatment, the whole blood viscosity, Incision viscosity, fibrinogen, erythrocyte aggregation index and plasma viscosity index were significantly lower than those in the control group and before treatment, the difference was statistically significant (P <0.05). Conclusion: Naoxintong capsule + ozagrel sodium can significantly improve the clinical symptoms of diabetic patients with cerebral infarction, and improve the prognosis of patients.